SMARCA4 and Peritoneal Fibrosis: In vivo, to further investigate the functional role of DMAMCL, the pro drug of MCL, in BRG1-induced peritoneal fibrosis, mice undergoing daily intraperitoneal injection of PD fluid were subjected to BRG1 overexpression plasmid through ultrasonic microbubbles at day 0 and day 14.